id	sid	tid	token	lemma	pos
ct-10023	1	1	2018	2018	NUM
ct-10023	1	2	:	:	PUNCT
ct-10023	1	3	luteinizing	luteinize	VERB
ct-10023	1	4	hormone	hormone	NOUN
ct-10023	1	5	receptor	receptor	NOUN
ct-10023	1	6	expression	expression	NOUN
ct-10023	1	7	in	in	ADP
ct-10023	1	8	canine	canine	PROPN
ct-10023	1	9	t	t	PROPN
ct-10023	1	10	-	-	PUNCT
ct-10023	1	11	lymphomacell	lymphomacell	ADJ
ct-10023	1	12	lines	line	NOUN
ct-10023	1	13	luteinizing	luteinize	VERB
ct-10023	1	14	hormone	hormone	NOUN
ct-10023	1	15	receptor	receptor	NOUN
ct-10023	1	16	expression	expression	NOUN
ct-10023	1	17	in	in	ADP
ct-10023	1	18	canine	canine	PROPN
ct-10023	1	19	t	t	PROPN
ct-10023	1	20	-	-	PUNCT
ct-10023	1	21	lymphoma	lymphoma	NOUN
ct-10023	1	22	cell	cell	NOUN
ct-10023	1	23	lines	line	NOUN
ct-10023	1	24	sabrina	sabrina	PROPN
ct-10023	1	25	gust	gust	PROPN
ct-10023	1	26	,	,	PUNCT
ct-10023	1	27	a	a	DET
ct-10023	1	28	alyssa	alyssa	PROPN
ct-10023	1	29	ettinger	ettinger	PROPN
ct-10023	1	30	,	,	PUNCT
ct-10023	1	31	a	a	DET
ct-10023	1	32	takuya	takuya	PROPN
ct-10023	1	33	mizuno	mizuno	PROPN
ct-10023	1	34	,	,	PUNCT
ct-10023	1	35	b	b	PROPN
ct-10023	1	36	michelle	michelle	PROPN
ct-10023	1	37	kutzlera	kutzlera	PROPN
ct-10023	1	38	adepartment	adepartment	PROPN
ct-10023	1	39	of	of	ADP
ct-10023	1	40	animal	animal	NOUN
ct-10023	1	41	and	and	CCONJ
ct-10023	1	42	rangeland	rangeland	NOUN
ct-10023	1	43	sciences	science	NOUN
ct-10023	1	44	,	,	PUNCT
ct-10023	1	45	oregon	oregon	PROPN
ct-10023	1	46	state	state	PROPN
ct-10023	1	47	university	university	PROPN
ct-10023	1	48	,	,	PUNCT
ct-10023	1	49	corvallis	corvallis	PROPN
ct-10023	1	50	,	,	PUNCT
ct-10023	1	51	or	or	CCONJ
ct-10023	1	52	;	;	PUNCT
ct-10023	2	1	blaboratory	blaboratory	NOUN
ct-10023	2	2	of	of	ADP
ct-10023	2	3	veterinary	veterinary	ADJ
ct-10023	2	4	internal	internal	ADJ
ct-10023	2	5	medicine	medicine	NOUN
ct-10023	2	6	,	,	PUNCT
ct-10023	2	7	the	the	DET
ct-10023	2	8	united	united	PROPN
ct-10023	2	9	graduate	graduate	PROPN
ct-10023	2	10	school	school	NOUN
ct-10023	2	11	of	of	ADP
ct-10023	2	12	veterinary	veterinary	ADJ
ct-10023	2	13	medicine	medicine	NOUN
ct-10023	2	14	,	,	PUNCT
ct-10023	2	15	yamaguchi	yamaguchi	PROPN
ct-10023	2	16	university	university	PROPN
ct-10023	2	17	,	,	PUNCT
ct-10023	2	18	1677	1677	NUM
ct-10023	2	19	–	–	PUNCT
ct-10023	2	20	1	1	NUM
ct-10023	2	21	yoshida	yoshida	PROPN
ct-10023	2	22	,	,	PUNCT
ct-10023	2	23	yamaguchi	yamaguchi	PROPN
ct-10023	2	24	753	753	NUM
ct-10023	2	25	–	–	PUNCT
ct-10023	2	26	8515	8515	NUM
ct-10023	2	27	,	,	PUNCT
ct-10023	2	28	japan	japan	PROPN
ct-10023	2	29	introduction	introduction	PROPN
ct-10023	2	30	canine	canine	NOUN
ct-10023	2	31	lymphoma	lymphoma	NOUN
ct-10023	2	32	is	be	AUX
ct-10023	2	33	a	a	DET
ct-10023	2	34	common	common	ADJ
ct-10023	2	35	malignant	malignant	ADJ
ct-10023	2	36	tumor	tumor	NOUN
ct-10023	2	37	in	in	ADP
ct-10023	2	38	dogs	dog	NOUN
ct-10023	2	39	.	.	PUNCT
ct-10023	3	1	luteinizing	luteinize	VERB
ct-10023	3	2	hormone	hormone	NOUN
ct-10023	3	3	receptors	receptor	NOUN
ct-10023	3	4	(	(	PUNCT
ct-10023	3	5	lhr	lhr	PROPN
ct-10023	3	6	)	)	PUNCT
ct-10023	3	7	have	have	AUX
ct-10023	3	8	been	be	AUX
ct-10023	3	9	found	find	VERB
ct-10023	3	10	in	in	ADP
ct-10023	3	11	normal	normal	ADJ
ct-10023	3	12	and	and	CCONJ
ct-10023	3	13	neoplastic	neoplastic	ADJ
ct-10023	3	14	canine	canine	NOUN
ct-10023	3	15	lymphatic	lymphatic	NOUN
ct-10023	3	16	tissue.1	tissue.1	SCONJ
ct-10023	3	17	the	the	DET
ct-10023	3	18	lhrs	lhrs	NOUN
ct-10023	3	19	have	have	AUX
ct-10023	3	20	also	also	ADV
ct-10023	3	21	been	be	AUX
ct-10023	3	22	found	find	VERB
ct-10023	3	23	in	in	ADP
ct-10023	3	24	human	human	ADJ
ct-10023	3	25	leukemia	leukemia	NOUN
ct-10023	3	26	cell	cell	NOUN
ct-10023	3	27	lines.2	lines.2	PROPN
ct-10023	3	28	therefore	therefore	ADV
ct-10023	3	29	,	,	PUNCT
ct-10023	3	30	we	we	PRON
ct-10023	3	31	hypothesized	hypothesize	VERB
ct-10023	3	32	that	that	SCONJ
ct-10023	3	33	lhr	lhr	PROPN
ct-10023	3	34	would	would	AUX
ct-10023	3	35	also	also	ADV
ct-10023	3	36	be	be	AUX
ct-10023	3	37	present	present	ADJ
ct-10023	3	38	in	in	ADP
ct-10023	3	39	canine	canine	NOUN
ct-10023	3	40	lymphoma	lymphoma	NOUN
ct-10023	3	41	cell	cell	NOUN
ct-10023	3	42	lines	line	NOUN
ct-10023	3	43	.	.	PUNCT
ct-10023	4	1	the	the	DET
ct-10023	4	2	objectives	objective	NOUN
ct-10023	4	3	of	of	ADP
ct-10023	4	4	the	the	DET
ct-10023	4	5	study	study	NOUN
ct-10023	4	6	were	be	AUX
ct-10023	4	7	to	to	PART
ct-10023	4	8	determine	determine	VERB
ct-10023	4	9	if	if	SCONJ
ct-10023	4	10	lhr	lhr	PROPN
ct-10023	4	11	is	be	AUX
ct-10023	4	12	expressed	express	VERB
ct-10023	4	13	in	in	ADP
ct-10023	4	14	cultured	cultured	ADJ
ct-10023	4	15	canine	canine	NOUN
ct-10023	4	16	t	t	PROPN
ct-10023	4	17	-	-	PUNCT
ct-10023	4	18	lymphoma	lymphoma	NOUN
ct-10023	4	19	cells	cell	NOUN
ct-10023	4	20	and	and	CCONJ
ct-10023	4	21	to	to	PART
ct-10023	4	22	quantify	quantify	VERB
ct-10023	4	23	the	the	DET
ct-10023	4	24	level	level	NOUN
ct-10023	4	25	of	of	ADP
ct-10023	4	26	cellular	cellular	ADJ
ct-10023	4	27	expression	expression	NOUN
ct-10023	4	28	of	of	ADP
ct-10023	4	29	lhr	lhr	NOUN
ct-10023	4	30	in	in	ADP
ct-10023	4	31	3	3	NUM
ct-10023	4	32	different	different	ADJ
ct-10023	4	33	cell	cell	NOUN
ct-10023	4	34	lines	line	NOUN
ct-10023	4	35	.	.	PUNCT
ct-10023	5	1	methods	method	NOUN
ct-10023	5	2	t	t	PROPN
ct-10023	5	3	-	-	PUNCT
ct-10023	5	4	lymphoma	lymphoma	NOUN
ct-10023	5	5	cell	cell	NOUN
ct-10023	5	6	lines	line	NOUN
ct-10023	5	7	(	(	PUNCT
ct-10023	5	8	clc	clc	PROPN
ct-10023	5	9	,	,	PUNCT
ct-10023	5	10	ema	ema	PROPN
ct-10023	5	11	,	,	PUNCT
ct-10023	5	12	clk	clk	PROPN
ct-10023	5	13	)	)	PUNCT
ct-10023	5	14	established	establish	VERB
ct-10023	5	15	from	from	ADP
ct-10023	5	16	primary	primary	ADJ
ct-10023	5	17	canine	canine	NOUN
ct-10023	5	18	lymphomas	lymphoma	NOUN
ct-10023	5	19	were	be	AUX
ct-10023	5	20	generously	generously	ADV
ct-10023	5	21	donated	donate	VERB
ct-10023	5	22	from	from	ADP
ct-10023	5	23	yamaguchi	yamaguchi	PROPN
ct-10023	5	24	university	university	PROPN
ct-10023	5	25	(	(	PUNCT
ct-10023	5	26	yamaguchi	yamaguchi	PROPN
ct-10023	5	27	,	,	PUNCT
ct-10023	5	28	japan	japan	PROPN
ct-10023	5	29	)	)	PUNCT
ct-10023	5	30	.	.	PUNCT
ct-10023	6	1	following	follow	VERB
ct-10023	6	2	receipt	receipt	NOUN
ct-10023	6	3	,	,	PUNCT
ct-10023	6	4	cells	cell	NOUN
ct-10023	6	5	were	be	AUX
ct-10023	6	6	thawed	thaw	VERB
ct-10023	6	7	and	and	CCONJ
ct-10023	6	8	cultured	cultured	ADJ
ct-10023	6	9	in	in	ADP
ct-10023	6	10	r10	r10	NOUN
ct-10023	6	11	complete	complete	ADJ
ct-10023	6	12	medium	medium	NOUN
ct-10023	6	13	(	(	PUNCT
ct-10023	6	14	rpmi1640	rpmi1640	NOUN
ct-10023	6	15	;	;	PUNCT
ct-10023	6	16	vwr	vwr	PROPN
ct-10023	6	17	life	life	PROPN
ct-10023	6	18	science	science	PROPN
ct-10023	6	19	,	,	PUNCT
ct-10023	6	20	visalia	visalia	PROPN
ct-10023	6	21	,	,	PUNCT
ct-10023	6	22	ca	ca	NOUN
ct-10023	6	23	)	)	PUNCT
ct-10023	6	24	supplemented	supplement	VERB
ct-10023	6	25	with	with	ADP
ct-10023	6	26	10	10	NUM
ct-10023	6	27	%	%	NOUN
ct-10023	6	28	fetal	fetal	ADJ
ct-10023	6	29	bovine	bovine	NOUN
ct-10023	6	30	serum	serum	NOUN
ct-10023	6	31	(	(	PUNCT
ct-10023	6	32	#	#	SYM
ct-10023	6	33	10803	10803	NUM
ct-10023	6	34	-	-	SYM
ct-10023	6	35	034	034	NUM
ct-10023	6	36	;	;	PUNCT
ct-10023	6	37	vwr	vwr	PROPN
ct-10023	6	38	)	)	PUNCT
ct-10023	6	39	and	and	CCONJ
ct-10023	6	40	100	100	NUM
ct-10023	6	41	u	u	NOUN
ct-10023	6	42	/	/	SYM
ct-10023	6	43	ml	ml	X
ct-10023	6	44	penicillin	penicillin	NOUN
ct-10023	6	45	with	with	ADP
ct-10023	6	46	100	100	NUM
ct-10023	6	47	μg	μg	NOUN
ct-10023	6	48	/	/	SYM
ct-10023	6	49	ml	ml	ADP
ct-10023	6	50	streptomycin	streptomycin	PROPN
ct-10023	6	51	(	(	PUNCT
ct-10023	6	52	#	#	SYM
ct-10023	6	53	sv30082.01	sv30082.01	NOUN
ct-10023	6	54	;	;	PUNCT
ct-10023	6	55	hyclone	hyclone	NOUN
ct-10023	6	56	,	,	PUNCT
ct-10023	6	57	south	south	PROPN
ct-10023	6	58	logan	logan	PROPN
ct-10023	6	59	,	,	PUNCT
ct-10023	6	60	ut	ut	PROPN
ct-10023	6	61	)	)	PUNCT
ct-10023	6	62	at	at	ADP
ct-10023	6	63	37ºc	37ºc	NOUN
ct-10023	6	64	at	at	ADP
ct-10023	6	65	a	a	DET
ct-10023	6	66	humidified	humidified	ADJ
ct-10023	6	67	5	5	NUM
ct-10023	6	68	%	%	NOUN
ct-10023	6	69	co2	co2	NOUN
ct-10023	6	70	incubator	incubator	NOUN
ct-10023	6	71	.	.	PUNCT
ct-10023	7	1	cells	cell	NOUN
ct-10023	7	2	were	be	AUX
ct-10023	7	3	cultured	cultured	ADJ
ct-10023	7	4	in	in	ADP
ct-10023	7	5	fresh	fresh	ADJ
ct-10023	7	6	r10	r10	NOUN
ct-10023	7	7	complete	complete	ADJ
ct-10023	7	8	media	medium	NOUN
ct-10023	7	9	every	every	DET
ct-10023	7	10	2	2	NUM
ct-10023	7	11	-	-	SYM
ct-10023	7	12	3	3	NUM
ct-10023	7	13	days	day	NOUN
ct-10023	7	14	at	at	ADP
ct-10023	7	15	a	a	DET
ct-10023	7	16	ratio	ratio	NOUN
ct-10023	7	17	of	of	ADP
ct-10023	7	18	1:4	1:4	NUM
ct-10023	7	19	(	(	PUNCT
ct-10023	7	20	ema	ema	PROPN
ct-10023	7	21	,	,	PUNCT
ct-10023	7	22	clk	clk	PROPN
ct-10023	7	23	)	)	PUNCT
ct-10023	7	24	or	or	CCONJ
ct-10023	7	25	1:9	1:9	NUM
ct-10023	7	26	(	(	PUNCT
ct-10023	7	27	clc	clc	PROPN
ct-10023	7	28	)	)	PUNCT
ct-10023	7	29	.	.	PUNCT
ct-10023	8	1	at	at	ADP
ct-10023	8	2	75	75	NUM
ct-10023	8	3	-	-	SYM
ct-10023	8	4	85	85	NUM
ct-10023	8	5	%	%	NOUN
ct-10023	8	6	confluence	confluence	NOUN
ct-10023	8	7	,	,	PUNCT
ct-10023	8	8	cells	cell	NOUN
ct-10023	8	9	were	be	AUX
ct-10023	8	10	washed	wash	VERB
ct-10023	8	11	to	to	PART
ct-10023	8	12	remove	remove	VERB
ct-10023	8	13	culture	culture	NOUN
ct-10023	8	14	media	medium	NOUN
ct-10023	8	15	and	and	CCONJ
ct-10023	8	16	transferred	transfer	VERB
ct-10023	8	17	to	to	ADP
ct-10023	8	18	eppendorf	eppendorf	PROPN
ct-10023	8	19	tubes	tubes	PROPN
ct-10023	8	20	.	.	PUNCT
ct-10023	9	1	nonspecific	nonspecific	ADJ
ct-10023	9	2	binding	binding	NOUN
ct-10023	9	3	was	be	AUX
ct-10023	9	4	blocked	block	VERB
ct-10023	9	5	with	with	ADP
ct-10023	9	6	mouse	mouse	NOUN
ct-10023	9	7	seroblock	seroblock	NOUN
ct-10023	9	8	fcr	fcr	X
ct-10023	9	9	(	(	PUNCT
ct-10023	9	10	1:10	1:10	NUM
ct-10023	9	11	dilution	dilution	NOUN
ct-10023	9	12	;	;	PUNCT
ct-10023	9	13	bio	bio	PROPN
ct-10023	9	14	-	-	ADJ
ct-10023	9	15	rad	rad	PROPN
ct-10023	9	16	antibodies	antibodie	VERB
ct-10023	9	17	,	,	PUNCT
ct-10023	9	18	richmond	richmond	PROPN
ct-10023	9	19	,	,	PUNCT
ct-10023	9	20	ca	ca	NOUN
ct-10023	9	21	)	)	PUNCT
ct-10023	9	22	.	.	PUNCT
ct-10023	10	1	cells	cell	NOUN
ct-10023	10	2	were	be	AUX
ct-10023	10	3	incubated	incubate	VERB
ct-10023	10	4	with	with	ADP
ct-10023	10	5	goat	goat	PROPN
ct-10023	10	6	polyclonal	polyclonal	PROPN
ct-10023	10	7	lhr	lhr	PROPN
ct-10023	10	8	(	(	PUNCT
ct-10023	10	9	1:50	1:50	NUM
ct-10023	10	10	dilution	dilution	NOUN
ct-10023	10	11	;	;	PUNCT
ct-10023	10	12	sc-26341	sc-26341	PROPN
ct-10023	10	13	,	,	PUNCT
ct-10023	10	14	santa	santa	PROPN
ct-10023	10	15	cruz	cruz	PROPN
ct-10023	10	16	biotechnology	biotechnology	PROPN
ct-10023	10	17	,	,	PUNCT
ct-10023	10	18	dallas	dallas	PROPN
ct-10023	10	19	,	,	PUNCT
ct-10023	10	20	tx	tx	PROPN
ct-10023	10	21	)	)	PUNCT
ct-10023	10	22	for	for	ADP
ct-10023	10	23	20	20	NUM
ct-10023	10	24	minutes	minute	NOUN
ct-10023	10	25	at	at	ADP
ct-10023	10	26	room	room	NOUN
ct-10023	10	27	temperature	temperature	NOUN
ct-10023	10	28	.	.	PUNCT
ct-10023	11	1	cells	cell	NOUN
ct-10023	11	2	were	be	AUX
ct-10023	11	3	washed	wash	VERB
ct-10023	11	4	and	and	CCONJ
ct-10023	11	5	then	then	ADV
ct-10023	11	6	incubated	incubate	VERB
ct-10023	11	7	with	with	ADP
ct-10023	11	8	goat	goat	PROPN
ct-10023	11	9	f(ab’)2	f(ab’)2	PROPN
ct-10023	11	10	igg	igg	PROPN
ct-10023	11	11	negative	negative	ADJ
ct-10023	11	12	control	control	PROPN
ct-10023	11	13	:	:	PUNCT
ct-10023	11	14	rpe	rpe	PROPN
ct-10023	11	15	(	(	PUNCT
ct-10023	11	16	1:10	1:10	NUM
ct-10023	11	17	dilution	dilution	NOUN
ct-10023	11	18	;	;	PUNCT
ct-10023	11	19	bio	bio	PROPN
ct-10023	11	20	-	-	ADJ
ct-10023	11	21	rad	rad	PROPN
ct-10023	11	22	antibodies	antibodie	VERB
ct-10023	11	23	,	,	PUNCT
ct-10023	11	24	richmond	richmond	PROPN
ct-10023	11	25	,	,	PUNCT
ct-10023	11	26	ca	ca	NOUN
ct-10023	11	27	)	)	PUNCT
ct-10023	11	28	.	.	PUNCT
ct-10023	12	1	the	the	DET
ct-10023	12	2	primary	primary	ADJ
ct-10023	12	3	antibody	antibody	NOUN
ct-10023	12	4	was	be	AUX
ct-10023	12	5	omitted	omit	VERB
ct-10023	12	6	in	in	ADP
ct-10023	12	7	the	the	DET
ct-10023	12	8	negative	negative	ADJ
ct-10023	12	9	controls	control	NOUN
ct-10023	12	10	.	.	PUNCT
ct-10023	13	1	the	the	DET
ct-10023	13	2	cells	cell	NOUN
ct-10023	13	3	were	be	AUX
ct-10023	13	4	analyzed	analyze	VERB
ct-10023	13	5	on	on	ADP
ct-10023	13	6	a	a	DET
ct-10023	13	7	cytoflex	cytoflex	NOUN
ct-10023	13	8	flow	flow	NOUN
ct-10023	13	9	cytometer	cytometer	NOUN
ct-10023	13	10	(	(	PUNCT
ct-10023	13	11	beckman	beckman	PROPN
ct-10023	13	12	coulter	coulter	PROPN
ct-10023	13	13	,	,	PUNCT
ct-10023	13	14	indianapolis	indianapolis	PROPN
ct-10023	13	15	,	,	PUNCT
ct-10023	13	16	in	in	ADP
ct-10023	13	17	)	)	PUNCT
ct-10023	13	18	at	at	ADP
ct-10023	13	19	the	the	DET
ct-10023	13	20	oregon	oregon	PROPN
ct-10023	13	21	state	state	PROPN
ct-10023	13	22	university	university	PROPN
ct-10023	13	23	core	core	NOUN
ct-10023	13	24	facility	facility	NOUN
ct-10023	13	25	.	.	PUNCT
ct-10023	14	1	results	result	VERB
ct-10023	14	2	the	the	DET
ct-10023	14	3	clc	clc	PROPN
ct-10023	14	4	,	,	PUNCT
ct-10023	14	5	ema	ema	PROPN
ct-10023	14	6	,	,	PUNCT
ct-10023	14	7	and	and	CCONJ
ct-10023	14	8	clk	clk	PROPN
ct-10023	14	9	cell	cell	NOUN
ct-10023	14	10	lines	line	NOUN
ct-10023	14	11	expressed	express	VERB
ct-10023	14	12	lhr	lhr	NOUN
ct-10023	14	13	in	in	ADP
ct-10023	14	14	45	45	NUM
ct-10023	14	15	%	%	NOUN
ct-10023	14	16	,	,	PUNCT
ct-10023	14	17	10	10	NUM
ct-10023	14	18	%	%	NOUN
ct-10023	14	19	,	,	PUNCT
ct-10023	14	20	and	and	CCONJ
ct-10023	14	21	35	35	NUM
ct-10023	14	22	%	%	NOUN
ct-10023	14	23	of	of	ADP
ct-10023	14	24	cells	cell	NOUN
ct-10023	14	25	.	.	PUNCT
ct-10023	15	1	in	in	ADP
ct-10023	15	2	all	all	DET
ct-10023	15	3	cell	cell	NOUN
ct-10023	15	4	lines	line	NOUN
ct-10023	15	5	,	,	PUNCT
ct-10023	15	6	the	the	DET
ct-10023	15	7	cell	cell	NOUN
ct-10023	15	8	population	population	NOUN
ct-10023	15	9	that	that	PRON
ct-10023	15	10	expressed	express	VERB
ct-10023	15	11	lhr	lhr	PROPN
ct-10023	15	12	was	be	AUX
ct-10023	15	13	smaller	small	ADJ
ct-10023	15	14	in	in	ADP
ct-10023	15	15	size	size	NOUN
ct-10023	15	16	(	(	PUNCT
ct-10023	15	17	forward	forward	ADV
ct-10023	15	18	scatter	scatter	NOUN
ct-10023	15	19	)	)	PUNCT
ct-10023	15	20	and	and	CCONJ
ct-10023	15	21	more	more	ADV
ct-10023	15	22	granular	granular	ADJ
ct-10023	15	23	(	(	PUNCT
ct-10023	15	24	side	side	NOUN
ct-10023	15	25	scatter	scatter	NOUN
ct-10023	15	26	)	)	PUNCT
ct-10023	15	27	.	.	PUNCT
ct-10023	16	1	there	there	PRON
ct-10023	16	2	was	be	VERB
ct-10023	16	3	no	no	DET
ct-10023	16	4	positive	positive	ADJ
ct-10023	16	5	staining	stain	VERB
ct-10023	16	6	evident	evident	NOUN
ct-10023	16	7	in	in	ADP
ct-10023	16	8	any	any	PRON
ct-10023	16	9	of	of	ADP
ct-10023	16	10	the	the	DET
ct-10023	16	11	negative	negative	ADJ
ct-10023	16	12	control	control	NOUN
ct-10023	16	13	samples	sample	NOUN
ct-10023	16	14	.	.	PUNCT
ct-10023	17	1	discussion	discussion	NOUN
ct-10023	17	2	this	this	PRON
ct-10023	17	3	is	be	AUX
ct-10023	17	4	the	the	DET
ct-10023	17	5	first	first	ADJ
ct-10023	17	6	study	study	NOUN
ct-10023	17	7	to	to	PART
ct-10023	17	8	show	show	VERB
ct-10023	17	9	lhr	lhr	ADJ
ct-10023	17	10	expression	expression	NOUN
ct-10023	17	11	in	in	ADP
ct-10023	17	12	canine	canine	NOUN
ct-10023	17	13	lymphoma	lymphoma	NOUN
ct-10023	17	14	cell	cell	NOUN
ct-10023	17	15	lines	line	NOUN
ct-10023	17	16	.	.	PUNCT
ct-10023	18	1	our	our	PRON
ct-10023	18	2	laboratory	laboratory	NOUN
ct-10023	18	3	is	be	AUX
ct-10023	18	4	currently	currently	ADV
ct-10023	18	5	investigating	investigate	VERB
ct-10023	18	6	the	the	DET
ct-10023	18	7	pro	pro	ADJ
ct-10023	18	8	-	-	ADJ
ct-10023	18	9	neoplastic	neoplastic	ADJ
ct-10023	18	10	effects	effect	NOUN
ct-10023	18	11	of	of	ADP
ct-10023	18	12	lhr	lhr	ADJ
ct-10023	18	13	activation	activation	NOUN
ct-10023	18	14	(	(	PUNCT
ct-10023	18	15	e.g.	e.g.	ADV
ct-10023	18	16	cell	cell	NOUN
ct-10023	18	17	proliferation	proliferation	NOUN
ct-10023	18	18	)	)	PUNCT
ct-10023	18	19	using	use	VERB
ct-10023	18	20	these	these	DET
ct-10023	18	21	cell	cell	NOUN
ct-10023	18	22	lines	line	NOUN
ct-10023	18	23	.	.	PUNCT
ct-10023	19	1	keywords	keyword	NOUN
ct-10023	19	2	:	:	PUNCT
ct-10023	19	3	cell	cell	NOUN
ct-10023	19	4	culture	culture	NOUN
ct-10023	19	5	,	,	PUNCT
ct-10023	19	6	dog	dog	NOUN
ct-10023	19	7	,	,	PUNCT
ct-10023	19	8	flow	flow	NOUN
ct-10023	19	9	cytometry	cytometry	NOUN
ct-10023	19	10	,	,	PUNCT
ct-10023	19	11	luteinizing	luteinize	VERB
ct-10023	19	12	hormone	hormone	NOUN
ct-10023	19	13	,	,	PUNCT
ct-10023	19	14	lymphoma	lymphoma	NOUN
ct-10023	19	15	acknowledgment	acknowledgment	NOUN
ct-10023	19	16	research	research	NOUN
ct-10023	19	17	funded	fund	VERB
ct-10023	19	18	by	by	ADP
ct-10023	19	19	oregon	oregon	PROPN
ct-10023	19	20	state	state	PROPN
ct-10023	19	21	university	university	PROPN
ct-10023	19	22	incentives	incentive	VERB
ct-10023	19	23	program	program	NOUN
ct-10023	19	24	references	reference	NOUN
ct-10023	19	25	1	1	NUM
ct-10023	19	26	.	.	PUNCT
ct-10023	20	1	ettinger	ettinger	PROPN
ct-10023	20	2	a	a	PROPN
ct-10023	20	3	,	,	PUNCT
ct-10023	20	4	zwida	zwida	PROPN
ct-10023	20	5	k	k	PROPN
ct-10023	20	6	,	,	PUNCT
ct-10023	20	7	kutzler	kutzler	NOUN
ct-10023	20	8	m	m	PROPN
ct-10023	20	9	:	:	PUNCT
ct-10023	20	10	normal	normal	ADJ
ct-10023	20	11	and	and	CCONJ
ct-10023	20	12	neoplastic	neoplastic	ADJ
ct-10023	20	13	canine	canine	NOUN
ct-10023	20	14	lymphocytes	lymphocytes	AUX
ct-10023	20	15	express	express	VERB
ct-10023	20	16	luteinizing	luteinizing	NOUN
ct-10023	20	17	hormone	hormone	NOUN
ct-10023	20	18	receptors	receptor	NOUN
ct-10023	20	19	.	.	PUNCT
ct-10023	21	1	clin	clin	PROPN
ct-10023	21	2	therio	therio	PROPN
ct-10023	21	3	2017;9:428	2017;9:428	NUM
ct-10023	21	4	.	.	PROPN
ct-10023	22	1	2	2	X
ct-10023	22	2	.	.	X
ct-10023	22	3	abdelbaset	abdelbaset	NOUN
ct-10023	22	4	-	-	PUNCT
ct-10023	22	5	ismail	ismail	PROPN
ct-10023	22	6	a	a	NOUN
ct-10023	22	7	,	,	PUNCT
ct-10023	22	8	borkowska	borkowska	PROPN
ct-10023	22	9	s	s	PROPN
ct-10023	22	10	,	,	PUNCT
ct-10023	22	11	janowska	janowska	ADJ
ct-10023	22	12	-	-	PUNCT
ct-10023	22	13	wieczorek	wieczorek	NOUN
ct-10023	22	14	a	a	NOUN
ct-10023	22	15	,	,	PUNCT
ct-10023	22	16	et	et	PROPN
ct-10023	22	17	al	al	PROPN
ct-10023	22	18	:	:	PUNCT
ct-10023	22	19	novel	novel	ADJ
ct-10023	22	20	evidence	evidence	NOUN
ct-10023	22	21	that	that	SCONJ
ct-10023	22	22	pituitary	pituitary	ADJ
ct-10023	22	23	gonadotropins	gonadotropin	NOUN
ct-10023	22	24	directly	directly	ADV
ct-10023	22	25	stimulate	stimulate	VERB
ct-10023	22	26	human	human	ADJ
ct-10023	22	27	leukemic	leukemic	ADJ
ct-10023	22	28	cells	cell	NOUN
ct-10023	22	29	-	-	PUNCT
ct-10023	22	30	studies	study	NOUN
ct-10023	22	31	of	of	ADP
ct-10023	22	32	myeloid	myeloid	ADJ
ct-10023	22	33	cell	cell	NOUN
ct-10023	22	34	lines	line	NOUN
ct-10023	22	35	and	and	CCONJ
ct-10023	22	36	primary	primary	ADJ
ct-10023	22	37	patient	patient	NOUN
ct-10023	22	38	aml	aml	PROPN
ct-10023	22	39	and	and	CCONJ
ct-10023	22	40	cml	cml	PROPN
ct-10023	22	41	cells	cell	NOUN
ct-10023	22	42	.	.	PUNCT
ct-10023	23	1	oncotarget	oncotarget	PROPN
ct-10023	23	2	2016;7:3033	2016;7:3033	NOUN
ct-10023	23	3	-	-	NUM
ct-10023	23	4	3046	3046	NUM
ct-10023	23	5	.	.	PUNCT
ct-10023	24	1	clinical	clinical	ADJ
ct-10023	24	2	theriogenology	theriogenology	NOUN
ct-10023	24	3	•	•	NOUN
ct-10023	24	4	volume	volume	NOUN
ct-10023	24	5	10	10	NUM
ct-10023	24	6	,	,	PUNCT
ct-10023	24	7	number	number	NOUN
ct-10023	24	8	3	3	NUM
ct-10023	24	9	•	•	NUM
ct-10023	24	10	september	september	PROPN
ct-10023	24	11	2018321	2018321	NUM